Imunon (LTS:0HUZ) Other Gross PPE : $2.18 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Imunon Other Gross PPE?

Imunon's Other Gross PPE for the quarter that ended in Mar. 2024 was $2.18 Mil.

Imunon's quarterly Other Gross PPE declined from Sep. 2023 ($2.49 Mil) to Dec. 2023 ($2.20 Mil) and declined from Dec. 2023 ($2.20 Mil) to Mar. 2024 ($2.18 Mil).

Imunon's annual Other Gross PPE declined from Dec. 2021 ($1.03 Mil) to Dec. 2022 ($0.53 Mil) but then increased from Dec. 2022 ($0.53 Mil) to Dec. 2023 ($2.20 Mil).

Imunon Other Gross PPE Historical Data

The historical data trend for Imunon's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imunon Other Gross PPE Chart

Imunon Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

1.78

1.39

1.03

0.53

2.20

Imunon Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															1.97	1.94	2.49	2.20	2.18

Imunon Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Imunon (LTS:0HUZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imunon Inc (LTS:0HUZ) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

IMNN:USA CBO:Germany

Address

997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648

Website

https://www.imunon.com

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Imunon (LTS:0HUZ) Headlines

No Headlines